四妙勇安汤对ApoE~(-/-)动脉粥样硬化小鼠IL-6和MCP-1的影响 : = Effect of Simiao Yongan Decoction on IL-6 and MCP-1 in ApoE~(-/-)Atherosclerotic Mice

目的:研究四妙勇安汤对高脂饲料喂养的ApoE基因敲除小鼠动脉粥样硬化炎症反应的干预作用。方法:采用高脂饲料喂养ApoE~(-/-)小鼠14周制备动脉粥样硬化模型,成模后随机分为5组:模型组,阳性药组(阿托伐他汀,2.57 mg·kg~(-1)),四妙勇安汤高剂量组(34.9 g·kg~(-1))、四妙勇安汤中剂量组(23.14 g·kg~(-1))和四妙勇安汤低剂量组(11.61 g·kg~(-1)),分别灌胃给药12周,同时以C57BL/6小鼠为正常对照组,给予去离子水灌胃12周。采用生化仪检测三酰甘油(TG)、总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)和低密度脂蛋白胆固醇(LDL-C)含量;HE染色观察主动脉血管形态,并测量主动脉内膜厚度(IT)、中膜厚度(MT)、血管管腔面积(LA)、粥样斑块面积(PA)、内中膜厚度比(IT/MT)、管腔狭窄率(PA/LA);采用流式高通量多因子检测技术检测血清中白介素-6(IL-6)、单核细胞趋化蛋白-1(MCP-1)炎症细胞因子表达。结果:与对照组相比,模型组小鼠血清TC、TG、LDL-C明显提高,HDL-C明显降低,PA、IT及IT/MT明显升高(P<0.01)。与模型组比较,四妙勇安汤能够明显降低ApoE~(-/-)小鼠主动脉PA、IT及IT/MT(P<0.01),并明显降低IL-6及MCP-1表达(P<0.01、P<0.05),但对血脂水平无明显的影响。结论:四妙勇安汤可以通过抑制炎症反应防治动脉粥样硬化,而不依赖血脂水平的变化。.

Objective:To study the intervention effect of Simiao Yongan decoction on atherosclerotic inflammatory response in ApoE knockout mice fed with high fat diet.Methods:ApoE~(-/-)mice were fed with high-fat diet for 14 weeks to prepare atherosclerosis model.After modeling,they were randomly divided into 5 groups:model group,positive drug group(atorvastatin,2.57 mg·kg~(-1)),Simiao Yongan decoction high dose group(34.9 g·kg~(-1)),Simiao Yongan decoction medium dose group(23.14 g·kg~(-1))and Simiao Yongan low dose group(11.61 g·kg~(-1)),respectively,administered by stomach 12 weeks.At the same time,C57 BL/6 mice were used as the normal control group,and deionized water was administered for 12 weeks.Using biochemical analyzer to detect triglyceride(TG),total cholesterol(TC),high-density lipoprotein cholesterol(HDL-C)and low-density lipoprotein cholesterol(low-density lipoprotein cholesterol,LDL-C)content;HE staining to observe aortic vascular morphology,and measurement of aortic intima thickness(IT),medial thickness(MT),vascular lumen area(LA),atheroma area(PA)intima-media thickness ratio(IT/MT),lumen stenosis rate(PA/LA);interleukin-6(IL-6)and mononuclear serum,and expression of inflammatory cytokines by monocyte chemoattractant protein-1(MCP-1)were measured by flow-through high-throughput multifactor detection.Results:Compared with the control group,serum TC,TG and LDL-C in the model group were significantly increased,HDL-C was significantly decreased,and PA,IT and IT/MT were significantly increased(P<0.01).Compared with the model group,Simiao Yongan decoction significantly reduced PA,IT and IT/MT(P<0.01)in ApoE~(-/-)mice,and significantly decreased IL-6 and MCP-1 expression(P<0.01,P<0.05),but had no significant effect on blood lipid levels.Conclusion:Simiao Yongan decoction can prevent atherosclerosis by inhibiting inflammatory response,independent of changes in blood lipid levels..

Medienart:

E-Artikel

Erscheinungsjahr:

2019-04-15 14:02

2019

Erschienen:

2019-04-15 14:02

Enthalten in:

Zur Gesamtaufnahme - year:2019

Enthalten in:

Zhong guo xian dai zhong yao - (2019), 04 vom: 15 14:02. Apr., Seite 441-447

Original Letters: Enthalten in 中国现代中药 (DE-600)2999274-6 (DE-600)2999274-6 北京市

Reihe:

China Academic Journals (CAJ), E, 医药卫生科技 = Medicine & Public Health

Sprache:

Chinesisch

Weiterer Titel:

Effect of Simiao Yongan Decoction on IL-6 and MCP-1 in ApoE~(-/-)Atherosclerotic Mice

Beteiligte Personen:

宋珂 [VerfasserIn]
侯彦宏 [Sonstige Person]
苏都娜 [Sonstige Person]
杨会 [Sonstige Person]
白云绮 [Sonstige Person]
李慧 [Sonstige Person]
娄利霞 [Sonstige Person]
赵一舟 [Sonstige Person]
吴爱明 [Sonstige Person]
图雅 [Sonstige Person]
聂波 [Sonstige Person]

Links:

oversea.cnki.net [lizenzpflichtig]

Themen:

中医
中国中医科学院中医药发展研究中心
中药学、方剂学
内蒙古赤峰市安定医院
动脉粥样硬化
北京中医药大学东直门医院中医内科学教育部和北京市重点实验室
北京中医药大学中药学院
医药、卫生
医药卫生科技
单核细胞趋化蛋白-1
四妙勇安汤
病理
白介素-6
ApoE~(-/-)小鼠
ApoE~(-/-)mice
Atherosclerosis
IL-6
MCP-1
Medicine & Public Health
Pathology
Simiao Yongan decoction
Traditional Chinese Medicinal Herbs

Anmerkungen:

Author info:SONG Ke;HOU Yan-hong;SU Du-na;YANG Hui;BAI Yun-qi;LI Hui;LOU Li-xia;ZHAO Yi-zhou;WU Ai-ming;TU Ya;NIE Bo;Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing,Dongzhimen Hospital,Beijing University of Chinese Medicine;Research Center for Chinese Medicine Development,China Academy of Chinese Medical Sciences;China Anding Hospital,Chifeng City,Inner Mongolia;School of Chinese Materia Medica,Beijing University of Chinese Medicine

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

CAJ630517932